Avail upto 30% off on all reports till July 31st.

Circulating Tumor Cells (CTC) Market - 2019-2028 - Global Trends, Market Size, Shares, Industry Dynamics, Opportunity Assessment, Competitive Intelligence

Date: Nov 26 2019
|
AllTheResearch (Featured Publisher)
|
Number of Pages: 148
|
Category: Medical Care

The global circulating tumor cells (ctc) market was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by the end of the forecast period, growing at a CAGR of XX% during the period from 2020 to 2028.

The research report segments the market from a relevancy perspective into the below segments and sub-segments with quantitative analysis done from 2018 to 2028 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2020 to 2028 to provide a reference for growth potential.

Key Market Players Analysed and Profiled in the Study Include:
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex

Market Segments and Sub-segments Covered in the Report:

Based on Product Type circulating tumor cells (ctc) market is segmented into:
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel

Based on Application circulating tumor cells (ctc) market is segmented into:
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others

Based on Geography circulating tumor cells (ctc) market is segmented into:
North America (U.S. and Canada)
Europe (U.K., Germany, France, Spain, Italy and Rest of Europe)
Asia Pacific (China, Japan, India, Indonesia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

This report covers an in-depth analysis of the circulating tumor cells (ctc) market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of circulating tumor cells (ctc) market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

Key Questions answered in the Report:

• What is the size of the overall circulating tumor cells (ctc) market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the circulating tumor cells (ctc) market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Market?
• What is the circulating tumor cells (ctc) market size at the regional and country level?
• Who are the key market players and their key competitors?
• Market value- chain and key trends impacting every node with reference to companies
• What are the strategies for growth adopted by the key players in circulating tumor cells (ctc) market?
• How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization?
• How financially strong are the key players in circulating tumor cells (ctc) market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)?
• What are the recent trends in circulating tumor cells (ctc) market? (M&A, partnerships, new product developments, expansions)

Years Considered During the Study:

Historical Year: 2018
Base Year: 2019
Forecast Period: 2020 to 2028

Chapter 1 Preface
   1.1 Report Description
          1.1.1 Purpose of the Report
          1.1.2 Target Audience
          1.1.3 USP and Key Offerings
   1.2 Research Scope
   1.3 Research Methodology
          1.3.1 Secondary Research
          1.3.2 Primary Research
          1.3.3 Expert Panel Review
          1.3.4 Approach Adopted
                1.3.4.1 Top-Down Approach
                1.3.4.2 Bottom-Up Approach
          1.3.5 Assumptions
   1.4 Market Segmentation Scope
Chapter 2 Executive Summary
   2.1 Market Summary
          2.1.1 Global Circulating Tumor Cells (CTC) Market, 2018-2026, (US$ Mn)
   2.2 Market Snapshot: Global Circulating Tumor Cells (CTC) Market
          2.2.1 Market Dynamics (DRO)
   2.3 Global Circulating Tumor Cells (CTC) Market, by Segment, 2019
          2.3.1 Global Circulating Tumor Cells (CTC) Market, by Region, 2019 (US$ Mn)
          2.3.2 Global Circulating Tumor Cells (CTC) Market, by Product Type, 2019 (US$ Mn)
          2.3.3 Global Circulating Tumor Cells (CTC) Market, by Application, 2019 (US$ Mn)
   2.4 Premium Insights
          2.4.1 Market In Developed Vs. Developing Economies, 2019 vs 2026
          2.4.2 Market Regional Life Cycle Analysis
          2.4.3 Pricing Analysis, by Region
                2.4.3.1 Pricing by Product
                2.4.3.2 Pricing by Applications
                2.4.3.3 Pricing by Geography/Regions
          2.4.4 Technological Integrations
          2.4.5 Supply Chain Analysis and Vendor Landscaping
          2.4.6 Emerging Player Analysis
          2.4.7 Major Investments in Market
          2.4.8 Mega Trend Analysis
          2.4.9 Regulatory Analysis
          2.4.10 Key Factors Influencing Purchasing/Buying Decisions
          2.4.11 Market Pain-Points and Unmet Needs
Chapter 3 Market Dynamics
   3.1 Market Overview
   3.2 Market Driver, Restraint and Opportunity Analysis
   3.3 Market Ecosystem Analysis
   3.4 Market Trends Analysis
   3.5 Industry Value Chain Analysis
   3.6 Market Analysis
          3.6.1 SWOT Analysis
          3.6.2 Porter's 5 Forces Analysis
   3.7 Analyst Views
Chapter 4 Global Circulating Tumor Cells (CTC) Market, by Product Type
   4.1 Market Overview, by Product Type
          4.1.1 Incremental Opportunity, by Product Type, 2019-2026

Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Chapter 5 Global Circulating Tumor Cells (CTC) Market, by Application
   5.1 Market Overview, by Application
          5.1.1 Incremental Opportunity, by Application, 2019-2026

Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
Chapter 6 Global Circulating Tumor Cells (CTC) Market, by Region
   6.1 Market Overview, by Region
          6.1.1 Global Circulating Tumor Cells (CTC) Market, by Region, 2018-2026, (US$ Mn)
   6.2 Incremental Opportunity, by Region, 2019
   6.3 North America Circulating Tumor Cells (CTC) Market
          6.3.1 North America Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
          6.3.2 North America Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
          6.3.3 North America Circulating Tumor Cells (CTC) Market, by Country, 2018-2026 (US$ Mn)
                6.3.3.1 U.S.
                   6.3.3.1.1 U.S. Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.3.3.1.2 U.S. Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.3.3.2 Canada
                   6.3.3.2.1 Canada Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.3.3.2.2 Canada Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
   6.4 Europe Circulating Tumor Cells (CTC) Market
          6.4.1 Europe Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
          6.4.2 Europe Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
          6.4.3 Europe Circulating Tumor Cells (CTC) Market, by Country, 2018-2026 (US$ Mn)
                6.4.3.1 U.K.
                   6.4.3.1.1 U.K. Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.1.2 U.K. Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.2 Germany
                   6.4.3.2.1 Germany Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.2.2 Germany Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.3 France
                   6.4.3.3.1 France Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.3.2 France Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.4 Italy
                   6.4.3.4.1 Italy Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.4.2 Italy Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.5 Spain
                   6.4.3.5.1 Spain Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.5.2 Spain Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.6 Rest of Europe
                   6.4.3.6.1 Rest of Europe Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.6.2 Rest of Europe Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
   6.5 Asia Pacific Circulating Tumor Cells (CTC) Market
          6.5.1 Asia Pacific Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
          6.5.2 Asia Pacific Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
          6.5.3 Asia Pacific Circulating Tumor Cells (CTC) Market, by Country, 2018-2026 (US$ Mn)
                6.5.3.1 China
                   6.5.3.1.1 China Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.1.2 China Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.2 India
                   6.5.3.2.1 India Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.2.2 India Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.3 Japan
                   6.5.3.3.1 Japan Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.3.2 Japan Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.4 Indonesia
                   6.5.3.4.1 Indonesia Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.4.2 Indonesia Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.5 Rest of Asia Pacific
                   6.5.3.5.1 Rest of Asia Pacific Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.5.2 Rest of Asia Pacific Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
   6.6 Latin America Circulating Tumor Cells (CTC) Market
          6.6.1 Latin America Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
          6.6.2 Latin America Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
          6.6.3 Latin America Circulating Tumor Cells (CTC) Market, by Country, 2018-2026 (US$ Mn)
                6.6.3.1 Brazil
                   6.6.3.1.1 Brazil Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.1.2 Brazil Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.6.3.2 Mexico
                   6.6.3.2.1 Mexico Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.2.2 Mexico Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.6.3.3 Rest of Latin America
                   6.6.3.3.1 Rest of Latin America Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.3.2 Rest of Latin America Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
   6.7 Middle East & Africa Circulating Tumor Cells (CTC) Market
          6.7.1 Middle East & Africa Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
          6.7.2 Middle East & Africa Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
          6.7.3 Middle East & Africa Circulating Tumor Cells (CTC) Market, by Region/Country, 2018-2026 (US$ Mn)
                6.7.3.1 GCC
                   6.7.3.1.1 GCC Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.1.2 GCC Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.7.3.2 South Africa
                   6.7.3.2.1 South Africa Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.2.2 South Africa Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
                6.7.3.3 Rest of Middle East & Africa
                   6.7.3.3.1 Rest of Middle East & Africa Circulating Tumor Cells (CTC) Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.3.2 Rest of Middle East & Africa Circulating Tumor Cells (CTC) Market, by Application, 2018-2026 (US$ Mn)
Chapter 7 Competitive Intelligence
   7.1 Market Players Present in Market Life Cycle
   7.2 Key Player Analysis
   7.3 Market Positioning
   7.4 Market Players Mapping, vis-à-vis Ecosystem
          7.4.1 By Segments
          7.4.2 By Region
   7.5 Strategies Adopted by Key Market Players
   7.6 Recent Developments in the Market
          7.6.1 Organic (New Product Launches, R&D, Financial, Technology)
          7.4.2 Inorganic (Mergers & Acquisitions, Partnership and Alliances, Fund Raise)
Chapter 8 Company Profiles - with focus on Company Fundamentals, Product Portfolio, Financial Analysis, Recent News and Developments, Key Strategic Instances, SWOT Analysis

AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Chapter 9 About Us

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.